IRadimed Corporation (NASDAQ: IRMD) is a Healthcare company (Medical - Devices) with a market capitalization of $1.1B. The Maz Rating grades it against the other companies in its sector.
IRadimed Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $83.45, IRadimed Corporation trades at 44.2x trailing earnings, 12.0x sales and 10.0x book value, with an EV/EBITDA of 31.5. Over the last twelve months it generated about $89M of revenue and $24M of net income. It runs a gross margin of 75.5%, an operating margin of 32.3% and a net margin of 26.8%. It shows return on equity of 23.9%, return on invested capital of 20.1% and a free cash flow yield of 2.4%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 8.99. Over the past 52 weeks the share price ranged from $76.35 to $107.90, with a beta of 0.91.
IRadimed Corporation pays a dividend yielding 1.56%, with 68% of earnings paid out. Its Maz Dividend Score is 1.10 out of 5, ranked against the other dividend payers in its sector (Safety 2.23, Growth 3.03, Yield 2.23, Consistency 1.03).
2 Wall Street analyst ratings cover the stock: 2 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.